IP Library Granted Patent US 11,642,402
Granted Patent B2
US 11,642,402 · App. 17/011,542 · Granted May 9, 2023

Method of producing immunotherapy vaccine

Inventors: Sadatoshi Sakuma (Tokyo, JP); Michiyo Osono (Tokyo, JP); Eriko Oka (Tokyo, JP)
Assignees: CYTIX INC.; KINKO CAPITAL CO.. LTD.
A61K39/0011C12N5/0639C12N13/00A61K2039/5154C12N2502/1114
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,642,402
App. No.
17/011,542
Granted
May 9, 2023
Kind
B2
Abstract

A method of producing an immunotherapy vaccine is provided. The method includes performing a heat treatment to exosomes separated from cancer cells or body fluids including blood of a cancer patient to promote inactivation of proteolytic enzymes in the exosomes, and introducing or co-culturing the exosomes in dendritic cells derived from blood of the cancer patient or a healthy person to make antigen-presenting cells.

Claims (5)

1. A method of producing an immunotherapy vaccine, the method comprising:

performing a heat treatment under a condition of 56° C. for 30 minutes on exosomes separated from cancer cells or bodily fluids from a cancer patient to promote inactivation of proteolytic enzymes in the exosomes; and

introducing or co-culturing the exosomes in the presence of dendritic cells derived from blood from the cancer patient or a healthy person to make antigen-presenting cells.

2. The method of producing an immunotherapy vaccine according to claim 1 , wherein the exosomes are maintained as stable particles by inactivating the proteolytic enzymes by the heat treatment.

3. The method of producing an immunotherapy vaccine according to claim 1 , wherein the dendritic cells are co-cultured with T cells to make cytotoxic T cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2020
From: SAKUMA, SADATOSHI; OSONO, MICHIYO; OKA, ERIKO
To: CYTIX INC.; KINKO CAPITAL CO., LTD.
Reel/Frame 053688/0056 →
Priority Claims (1)
JP JP2019-163625 · Sep 9, 2019 · national
Continuity (1)
Related Publication 20210069311A1 · Mar 11, 2021